Keywords
Transgender
Gender Identity
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To comprehensively and deeply analyze the main dermatoses identified in transgender individuals undergoing Gender Affirming Hormonal Therapy (GAHT). Methods: This is an integrative literature review, with inclusion criteria being primary articles in English, Portuguese, and Spanish, published in the last 10 years, addressing dermatoses in transgender individuals undergoing GAHT. Results: After searches in the PubMed (129), Cochrane (1), Lilacs (60), Scielo (0) and Acervo+ Index Base (0) databases and removal of duplicates (37), 153 studies were selected for title analysis, leaving, after this analysis, 75 articles for abstract reading. After this screening, suitable studies (16) were read in full, leading to the final use of 6 articles in the review. Final considerations: It is considered that the main dermatoses on the skin of transgender individuals are melasma, xerosis, and alopecia in trans women, and acne and alopecia in trans men. Careful and inclusive clinical management is necessary to address dermatoses in transgender patients to ensure successful gender affirmation.
References
BOOS MD, et al. Management of acne in transgender and gender diverse youth part 1: Gender affirming care and risk factors for the development of acne. Pediatric dermatology, 2022; 39(6): 866–869.
CAMPOS-MUÑOZ L, et al. Transgender adolescents and acne: A cases series. Pediatric dermatology, 2018; 35(3): e155–e158.
D’HOORE L, T’SJOEN G. Gender-affirming hormone therapy: An updated literature review with an eye on the future. Journal of Internal Medicine, 2022; 291(5): 574-592.
GINSBERG BA. Dermatologic care of the transgender patient. International journal of women's dermatology, 2017; 3(1): 65–67.
HEMBREE WC, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolismo, 2017; 102(11): 3869-3903.
IRWIG MS. Testosterone therapy for transgender men. The lancet. Diabetes & endocrinology, 2017; 5(4): 301-311.
IWAMOTO SJ, et al. Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic advances in endocrinology and metabolism, 2019; 10: 2042018819871166.
LEE G, et al. Acne fulminans in a transgender boy after an increase in testosterone dosage. JAAD case reports, 2022; 21: 32–34.
MOTOSKO CC, TOSTI A. Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature. Dermatology and therapy, 2021; 11(5): 1457–1468.
MOTOSKO CC, et al. Acne: a side-effect of masculinizing hormonal therapy in transgender patients. The British journal of dermatology, 2019; 180(1): 26–30.
MUNDLURU SN, LARSON AR. Medical dermatologic conditions in transgender women. International journal of women's dermatology, 2018; 4(4): 212–215.
RAGMANAUSKAITE L, et al. Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager. Dermatologic clinics, 2020; 38(2): 219–226.
RAHMAT A, et al. “Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands.” International journal of dermatology, 2023; 62(7): 882-887
REISNER SL, et al. Global health burden and needs of transgender populations: a review. Lancet (London, England), 2016; 388(10042): 412–436.
RUTNIN S, et al. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study. Transgender health, 2023; 8(1): 89–99.
SULLIVAN P, et al. Issues in transgender dermatology: A systematic review of the literature. Journal of the American Academy of Dermatology, 2019; 81(2): 438–447.
SWINK SM, CASTELO-SOCCIO L. Dermatologic considerations for transgender and gender diverse youth. Pediatric dermatology, 2021; 38 (2): 58–64.
THORESON N, et al. Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy. JAMA dermatology, 2021;157(3): 290–295.
YEUNG H, et al. Dermatologic conditions in transgender populations. Endocrinology and metabolism clinics of North America, 2019; 48(2): 429-440.
YEUNG H. et al. Dermatologic care for lesbian, gay, bisexual, and transgender persons: Terminology, demographics, health disparities, and approaches to care. Journal of the American Academy of Dermatology, 2019; 80(3): 581–589.